PCI Pharma Services ESG Report FY23

Leading CDMO, PCI Pharma Services, announces its first comprehensive Environmental, Social, and Governance (ESG) report. This report signifies PCI's commitment to environmental and social responsibility, outlining its ambitious sustainability goals and achievements across various categories.

Highlighting its dedication to transparency, PCI emphasizes its significant improvement in EcoVadis' Sustainability Performance rankings, securing a Bronze Medal in both 2022 and 2023. This achievement reflects a 70% improvement from 2021 and positions PCI among the top third of over 130,000 assessed companies.

The report sheds light on PCI's collaborative approach to ESG, outlining its commitment to stakeholder engagement and employee empowerment. Furthermore, it details PCI's data-driven decision-making, aiming to achieve ambitious goals set in accordance with the UN Sustainable Development Goals and the 1.5°C emissions scenarios.

Delving into PCI's ESG journey, the report acknowledges the company's longstanding commitment to social and environmental well-being, even predating the formalization of its ESG program in 2021. This commitment is underscored by PCI's core values: people, communities, and accountability.

By emphasizing its commitment to transparency, collaboration, and measurable results, PCI's ESG report offers valuable insights for stakeholders interested in the company's sustainability efforts.